Workshop | Mixed
Event Title
FDA/CDER Office of Clinical Pharmacology and International Society of Pharmacometrics (ISoP) Public Workshop: Using Modeling and Simulation to Evaluate the Effects of Intrinsic and Extrinsic Factors
October 16, 2023
- Date:
- October 16, 2023
- Time:
- 10:00 a.m. - 4:30 p.m. ET
Workshop Recording
About
The meeting was held October 16, 2023 as a Hybrid event, hosted from the FDA White Oak campus, 10:00am-4:30pm.
Goals and Objectives
- To discuss best practices and methods to incorporate quantitative methods into the clinical development of oncologic products as a means to support dosage optimization that has been strongly advocated for in recent engagements.
- To describe the impact of dosage exploration on the benefit/risk assessment for oncologic products and highlight ongoing efforts from regulatory agencies, academic centers, and industry to shift current practices used to select dosages for investigation in clinical trials and identify the recommended dosage for marketing applications and labeling.
- To discuss the role of model-based approaches in investigating how various intrinsic and extrinsic factors can influence the investigation and selection of a dosage(s) during clinical development.
Who Should Attend
This workshop is intended for interested parties regarding ongoing efforts; parties interested in continued advocacy for alternatives to traditional dose finding for oncologic drugs. The primary audience includes, clinical pharmacologists, pharmacometricians, pharmacologists/toxicologists, clinicians/healthcare providers, statisticians, patients, and patient advocates.
Meeting Materials
- Final Agenda Oct 16 (PDF - 163 KB)
- Session 1a Bi Regulations and Recommendations Slides Oct 16 (PDF - 1.0 MB)
- Session 1b Nightingale FDA Panel Presentation Older Adults with Cancer Oct 16 (PDF - 2.2 MB)
- Session 1c Mizuno Slides Oct 16 (PDF - 2.4 MB)
- Session 2a Okusanya Expanding Clinical Trial Eligibility Oct 16 (PDF - 4.0 MB)
- Session 2b Ramamoorthy REGA FDA-ISoP Oct 16 (PDF - 1.29 MB)
- Session 2c Venkatakrishnan Oct 16 (PDF - 1.6 MB)
- Session 2d Kijima PMDA Experience with Dosage Selection Oct 16 (PDF - 593 KB)
- Session 3a Booth POFE DDI Oct 16 (PDF - 876 KB)
- Session 3b Zhang Food Effect Oct 16 (PDF - 681 KB)
- Session 3c Zhao FDAMIDD DDI Oct 16 (PDF - 1.72 MB)
Contact
ISoP:
Jennifer Pastore Monroy, CAE
Executive Director, International Society of Pharmacometrics
jennifer.monroy@go-isop.org
Bridgewater, NJ 08807
FDA/CDER:
Bernadette Johnson-Williams, DHSc, MEd
Office of Clinical Pharmacology/OTS/CDER
bernadette.johnson-williams@fda.hhs.gov
Silver Spring, MD 21029
Event Materials
Title | File Type/Size |
---|---|
ISoP Final Agenda | pdf (162.56 KB) |
Session 1a_ Bi Regulations and Recommendations Slides Oct 16 | pdf (1.01 MB) |
Session 1b Nightingale FDA Panel Presentation Older Adults with Cancer Oct 16 | pdf (2.21 MB) |
Session 1c Mizuno Slides Oct 16 | pdf (2.41 MB) |
Session 2c Venkatakrishnan Oct 16 | pdf (1.61 MB) |
Session 2a Okusanya Expanding Clinical Trial Eligibility Oct 16 | pdf (4.01 MB) |
Session 2b Ramamoorthy REGA FDA-ISoP Oct 16 | pdf (1.29 MB) |
Session 2d Kijima PMDA Experience with Dosage Selection Oct 16 | pdf (592.93 KB) |
Session 3c Zhao FDAMIDD DDI Oct 16 | pdf (1.72 MB) |
Session 3b Zhang Food Effect Oct 16 | pdf (680.53 KB) |
Session 3a Booth POFE DDI Oct 16 | pdf (876.36 KB) |